From: Thursday, November 5, 2009
To: Friday, November 6, 2009
Venue:
Shanghai, China
Agenda:
Upon the establishment and improvement of the China Drug Supervision and Administration System, the global biomedical industry value chain has been shifting toward the biotech industry zones in China. The fastest-growing biomedical market portfolio in China is expected to be dominated by monoclonal antibody, gene therapeutics and vaccines for anti-infection and anti-cancer diagnostics and therapeutics. China Biomedical Innovations Conference 2009 will include intensive onsite demonstrations and a dedicated stem cell biology workshop. There also will be an interactive business partnership salon. For more information, visit www.biochinaforum.com.
